Stay updated on Brexanolone in COVID-19 ARDS Clinical Trial

Sign up to get notified when there's something new on the Brexanolone in COVID-19 ARDS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Brexanolone in COVID-19 ARDS Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    New study locations added across several states (California, Georgia, Massachusetts, Michigan, Nevada, North Carolina, Virginia, and Washington). Existing state location sections were removed.
    Difference
    1.0%
    Check dated 2025-12-23T23:05:02.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    Revision note added: v3.3.2. Revision note removed: v3.2.0. No visible changes to study details, eligibility criteria, or page layout.
    Difference
    0.1%
    Check dated 2025-11-25T11:27:29.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The page no longer displays the government funding operating status notice. It previously directed users to cc.nih.gov and opm.gov for updates.
    Difference
    0.4%
    Check dated 2025-11-18T07:14:03.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    New screenshot shows a reorganized layout and updated styling of the page header and sections. Core study data such as title, eligibility criteria, locations, enrollment, and primary outcomes appear unchanged.
    Difference
    0.5%
    Check dated 2025-11-03T21:17:10.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    Updated status notice and version to v3.2.0, replacing v3.1.0; added information about government funding lapse and operating status, and where to find details.
    Difference
    5%
    Check dated 2025-10-06T05:37:02.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    Updated page now shows Revision: v3.1.0 and removes several drug-safety topic sections (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs).
    Difference
    0.6%
    Check dated 2025-09-29T03:07:28.000Z thumbnail image

Stay in the know with updates to Brexanolone in COVID-19 ARDS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Brexanolone in COVID-19 ARDS Clinical Trial page.